142 related articles for article (PubMed ID: 35644071)
1. A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept.
MacDonald T; Gallo AT; Basso-Hulse G; Bennett KS; Hulse GK
Drug Alcohol Depend; 2022 Jul; 236():109501. PubMed ID: 35644071
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of patients treated with low-dose flumazenil for benzodiazepine detoxification: A description of 26 participants.
MacDonald T; Gallo AT; Basso-Hulse G; Hulse GK
Drug Alcohol Depend; 2022 Aug; 237():109517. PubMed ID: 35688053
[TBL] [Abstract][Full Text] [Related]
3. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.
Gallo AT; Hulse G
J Psychopharmacol; 2021 Mar; 35(3):211-220. PubMed ID: 33426982
[TBL] [Abstract][Full Text] [Related]
5. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
Mintzer MZ; Stoller KB; Griffiths RR
Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine dependence and its treatment with low dose flumazenil.
Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
[TBL] [Abstract][Full Text] [Related]
7. Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study.
Saxon L; Hjemdahl P; Hiltunen AJ; Borg S
Psychopharmacology (Berl); 1997 May; 131(2):153-60. PubMed ID: 9201803
[TBL] [Abstract][Full Text] [Related]
8. βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats.
Divljaković J; Milić M; Namjoshi OA; Tiruveedhula VV; Timić T; Cook JM; Savić MM
Brain Res Bull; 2013 Feb; 91():1-7. PubMed ID: 23149168
[TBL] [Abstract][Full Text] [Related]
9. Flumazenil-insensitive benzodiazepine binding sites in GABA
Cao Y; Yan H; Yu G; Su R
Life Sci; 2019 Dec; 239():117033. PubMed ID: 31697950
[TBL] [Abstract][Full Text] [Related]
10. Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: A placebo-controlled pilot study.
Kasteleijn-Nolst Trenité DG; Groenwold RH; Schmidt B; Löscher W
Epilepsy Res; 2016 May; 122():30-6. PubMed ID: 26921854
[TBL] [Abstract][Full Text] [Related]
11. Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys.
McMahon LR; Javors MA; France CP
Psychopharmacology (Berl); 2007 May; 192(1):135-45. PubMed ID: 17245585
[TBL] [Abstract][Full Text] [Related]
12. Increase in expression of the GABA(A) receptor alpha(4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists.
Follesa P; Cagetti E; Mancuso L; Biggio F; Manca A; Maciocco E; Massa F; Desole MS; Carta M; Busonero F; Sanna E; Biggio G
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):138-48. PubMed ID: 11483250
[TBL] [Abstract][Full Text] [Related]
13. Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?
Gallo A; MacDonald T; Bennett K; Basso-Hulse G; Hulse G
J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233814
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Benzodiazepines Positively Modulate GABA
Wang N; Lian J; Cao Y; Muheyati A; Yuan S; Ma Y; Zhang S; Yu G; Su R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008465
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
[TBL] [Abstract][Full Text] [Related]
16. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
17. Physical dependence on diazepam: precipitation of abstinence syndromes by peripheral and central benzodiazepine receptor antagonists.
Martinez JA; Fargeas MJ; Bueno L
Pharmacol Biochem Behav; 1992 Feb; 41(2):461-4. PubMed ID: 1315441
[TBL] [Abstract][Full Text] [Related]
18. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.
Mintzer MZ; Griffiths RR
Psychopharmacology (Berl); 2005 Mar; 178(2-3):259-67. PubMed ID: 15452683
[TBL] [Abstract][Full Text] [Related]
19. A Placebo-Controlled Randomized Trial of Vigabatrin in the Management of Acute Alcohol Withdrawal.
Williams J; Collins L; Norman A; O'Neill H; Lloyd-Jones M; Ogden E; Bonomo Y; Pastor A
Alcohol Alcohol; 2023 Jan; 58(1):40-45. PubMed ID: 36161306
[TBL] [Abstract][Full Text] [Related]
20. Flumazenil: US clinical pharmacology studies.
Dunton AW; Schwam E; Pitman V; McGrath J; Hendler J; Siegel J
Eur J Anaesthesiol Suppl; 1988; 2():81-95. PubMed ID: 2842144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
